Search

Lori Lynn Baker

Examiner (ID: 17012, Phone: (571)272-4971 , Office: P/3754 )

Most Active Art Unit
3754
Art Unit(s)
3764, 3754, 3751
Total Applications
2962
Issued Applications
2221
Pending Applications
186
Abandoned Applications
595

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20510100 [patent_doc_number] => 20260034199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-02-05 [patent_title] => Methods Of Treating Plantar Fibromatosis [patent_app_type] => utility [patent_app_number] => 19/288143 [patent_app_country] => US [patent_app_date] => 2025-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 84885 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19288143 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/288143
Methods Of Treating Plantar Fibromatosis Jul 31, 2025 Pending
Array ( [id] => 20321351 [patent_doc_number] => 20250333439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-30 [patent_title] => PURIFIED PROTEIN COMPOSITIONS AND METHODS OF PRODUCTION [patent_app_type] => utility [patent_app_number] => 19/264681 [patent_app_country] => US [patent_app_date] => 2025-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55674 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19264681 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/264681
PURIFIED PROTEIN COMPOSITIONS AND METHODS OF PRODUCTION Jul 8, 2025 Pending
Array ( [id] => 20480581 [patent_doc_number] => 12529052 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-20 [patent_title] => Euglobulin-based method for determining the biological activity of defibrotide [patent_app_type] => utility [patent_app_number] => 19/173657 [patent_app_country] => US [patent_app_date] => 2025-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 1354 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19173657 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/173657
Euglobulin-based method for determining the biological activity of defibrotide Apr 7, 2025 Issued
Array ( [id] => 20492859 [patent_doc_number] => 12534722 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-27 [patent_title] => Euglobulin-based method for determining the biological activity of defibrotide [patent_app_type] => utility [patent_app_number] => 19/173652 [patent_app_country] => US [patent_app_date] => 2025-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 1329 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 85 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19173652 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/173652
Euglobulin-based method for determining the biological activity of defibrotide Apr 7, 2025 Issued
Array ( [id] => 20657920 [patent_doc_number] => 20260109959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-04-23 [patent_title] => METHODS OF TREATING PULMONARY SARCOIDOSIS WITH DNA NUCLEASES [patent_app_type] => utility [patent_app_number] => 19/031963 [patent_app_country] => US [patent_app_date] => 2025-01-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1147 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19031963 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/031963
METHODS OF TREATING PULMONARY SARCOIDOSIS WITH DNA NUCLEASES Jan 17, 2025 Pending
Array ( [id] => 19984027 [patent_doc_number] => 20250122249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-04-17 [patent_title] => PURIFICATION OF PHYCOBILIPROTEINS [patent_app_type] => utility [patent_app_number] => 18/910453 [patent_app_country] => US [patent_app_date] => 2024-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1156 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18910453 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/910453
PURIFICATION OF PHYCOBILIPROTEINS Oct 8, 2024 Pending
Array ( [id] => 19745667 [patent_doc_number] => 20250034232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-30 [patent_title] => von Willebrand Factor Proteins for Treating Bleeding Disorders [patent_app_type] => utility [patent_app_number] => 18/883537 [patent_app_country] => US [patent_app_date] => 2024-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10740 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18883537 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/883537
von Willebrand Factor Proteins for Treating Bleeding Disorders Sep 11, 2024 Pending
Array ( [id] => 20179811 [patent_doc_number] => 20250263769 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-21 [patent_title] => METHOD OF PRODUCING BIOLOGICALLY ACTIVE VITAMIN K DEPENDENT PROTEINS BY RECOMBINANT METHODS [patent_app_type] => utility [patent_app_number] => 18/821185 [patent_app_country] => US [patent_app_date] => 2024-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5548 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18821185 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/821185
METHOD OF PRODUCING BIOLOGICALLY ACTIVE VITAMIN K DEPENDENT PROTEINS BY RECOMBINANT METHODS Aug 29, 2024 Pending
Array ( [id] => 19642907 [patent_doc_number] => 20240417427 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-19 [patent_title] => Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances [patent_app_type] => utility [patent_app_number] => 18/817164 [patent_app_country] => US [patent_app_date] => 2024-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41799 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18817164 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/817164
Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances Aug 26, 2024 Pending
Array ( [id] => 20100490 [patent_doc_number] => 20250230426 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-17 [patent_title] => RECOMBINANT VITAMIN K DEPENDENT PROTEINS WITH HIGH SIALIC ACID CONTENT AND METHODS OF PREPARING SAME [patent_app_type] => utility [patent_app_number] => 18/815115 [patent_app_country] => US [patent_app_date] => 2024-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2290 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18815115 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/815115
RECOMBINANT VITAMIN K DEPENDENT PROTEINS WITH HIGH SIALIC ACID CONTENT AND METHODS OF PREPARING SAME Aug 25, 2024 Pending
Array ( [id] => 19629568 [patent_doc_number] => 20240408017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-12 [patent_title] => THROMBOLYTIC MICROSPHERES TO DISSOLVE VASO-OCCLUSIVE CLOTS [patent_app_type] => utility [patent_app_number] => 18/812320 [patent_app_country] => US [patent_app_date] => 2024-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17704 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18812320 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/812320
THROMBOLYTIC MICROSPHERES TO DISSOLVE VASO-OCCLUSIVE CLOTS Aug 21, 2024 Pending
Array ( [id] => 19629733 [patent_doc_number] => 20240408182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-12 [patent_title] => COMPOSITIONS AND METHODS FOR BIODEGRADING ALCOHOL [patent_app_type] => utility [patent_app_number] => 18/811618 [patent_app_country] => US [patent_app_date] => 2024-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17082 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18811618 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/811618
COMPOSITIONS AND METHODS FOR BIODEGRADING ALCOHOL Aug 20, 2024 Pending
Array ( [id] => 19691312 [patent_doc_number] => 20250009857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-09 [patent_title] => NUTRACEUTICAL COMPOSITION BASED ON PINEAPPLE AND PLANT EXTRACTS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME [patent_app_type] => utility [patent_app_number] => 18/765199 [patent_app_country] => US [patent_app_date] => 2024-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6330 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18765199 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/765199
NUTRACEUTICAL COMPOSITION BASED ON PINEAPPLE AND PLANT EXTRACTS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME Jul 4, 2024 Pending
Array ( [id] => 20445586 [patent_doc_number] => 20260002303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-01 [patent_title] => PROCESS FOR MANUFACTURING A POTENTIATING PROTEIN COMPOSITION WITH INCREASED EFFICIENCY AND LONGEVITY AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/756409 [patent_app_country] => US [patent_app_date] => 2024-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18756409 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/756409
PROCESS FOR MANUFACTURING A POTENTIATING PROTEIN COMPOSITION WITH INCREASED EFFICIENCY AND LONGEVITY AND USES THEREOF Jun 26, 2024 Pending
Array ( [id] => 19512086 [patent_doc_number] => 20240343772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-17 [patent_title] => Fusion protein and its preparation method for intermediate polypeptide of Semaglutide [patent_app_type] => utility [patent_app_number] => 18/755691 [patent_app_country] => US [patent_app_date] => 2024-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5432 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18755691 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/755691
Fusion protein and its preparation method for intermediate polypeptide of Semaglutide Jun 26, 2024 Issued
Array ( [id] => 20427647 [patent_doc_number] => 20250389737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-25 [patent_title] => FACTOR Xa REAGENT [patent_app_type] => utility [patent_app_number] => 18/748840 [patent_app_country] => US [patent_app_date] => 2024-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2444 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18748840 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/748840
FACTOR Xa REAGENT Jun 19, 2024 Pending
Array ( [id] => 19601449 [patent_doc_number] => 20240392329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-28 [patent_title] => MICROORGANISMS AND METHODS FOR THE PRODUCTION OF OXYGENATED COMPOUNDS FROM HEXOSES [patent_app_type] => utility [patent_app_number] => 18/737619 [patent_app_country] => US [patent_app_date] => 2024-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 111984 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18737619 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/737619
MICROORGANISMS AND METHODS FOR THE PRODUCTION OF OXYGENATED COMPOUNDS FROM HEXOSES Jun 6, 2024 Abandoned
Array ( [id] => 20330818 [patent_doc_number] => 12461089 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-04 [patent_title] => Olfactory receptor involved in the perception of musk fragrance and the use thereof [patent_app_type] => utility [patent_app_number] => 18/406031 [patent_app_country] => US [patent_app_date] => 2024-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 17645 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18406031 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/406031
Olfactory receptor involved in the perception of musk fragrance and the use thereof May 29, 2024 Issued
Array ( [id] => 19862606 [patent_doc_number] => 20250101392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => Enzyme Variants With Improved Ester Synthase Properties [patent_app_type] => utility [patent_app_number] => 18/662446 [patent_app_country] => US [patent_app_date] => 2024-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39913 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662446 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/662446
Enzyme variants with improved ester synthase properties May 12, 2024 Issued
Array ( [id] => 19543456 [patent_doc_number] => 20240360492 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => COAGULATION AND FIBRINOLYSIS ASSAYS [patent_app_type] => utility [patent_app_number] => 18/657130 [patent_app_country] => US [patent_app_date] => 2024-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14351 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18657130 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/657130
COAGULATION AND FIBRINOLYSIS ASSAYS May 6, 2024 Pending
Menu